HeartStart XL Defibrillator/Monitor

HeartStart XL Defibrillator/Monitor

Philips HeartStart XL Defibrillator/Monitor

An easy-to-use, compact, lightweight defibrillator/monitor with manual and AED capabilities for ALS and BLS clinicians

The Philips HeartStart XL Defibrillator/Monitor is designed to meet a wide variety of defibrillation and monitoring needs in one lightweight, easy-to-use device.

 

At just under 14 lbs., the HeartStart XL is easily transported throughout the hospital to the site where cardiac care is needed. A combination manual device with automated external defibrillator capabilities, HeartStart XL enables the first caregiver on the scene, whether an ALS or BLS clinician, to deliver potentially lifesaving defibrillation therapy.

 

In AED mode, voice prompts and text messages guide BLS users through the defibrillation process, while the HeartStart XL continuously monitors and displays the patient's ECG.

 

Upon the arrival of ALS personnel, HeartStart XL is easily switched from AED to manual mode, allowing operators to access the unit's advanced therapeutic features such as selectable energy (from 2 to 200 Joules), non-invasive pacing (optional), SpO2 (optional) and synchronized cardioversion.

 

Quick charging 

Charges to highest energy level, 200 Joules, in less than 3.5 seconds.

 

SMART Biphasic technology

Philips pioneered biphasic therapy in external defibrillators and today biphasic is the standard of care. While all manufacturers have followed our lead, they employ distinctive approaches. Philips uses a combination of high current to maximize effectiveness and lower energy doses to minimize side effects that are harmful to a fragile heart.  Philips biphasic therapy has been rigorously studied and is backed by a substantial body of peer-reviewed, published data. It has been clinically proven to deliver high first shock efficacy for long downtime sudden cardiac arrest (SCA) patients, and effectively defibrillate across the full spectrum of patients. 

 

Real-time impedance compensation  

Philips success across a broad patient population is due in part to its real-time impedance compensation technology, which automatically measures the patient’s chest impedance and optimizes the waveform for every shock.  Patients receive personalized therapy for the best chance of a positive outcome.1-16 

 

Synchronized cardioversion 

Philips' SMART Biphasic waveform has undergone clinical testing, demonstrating its effectiveness for cardioversion of atrial fibrillation. 15,16,17 

 

Easy to use

  • 1-2-3 operation—True 1-2-3 operation makes defibrillation intuitive for all users.
  • AED mode—Voice and text prompts guide users through the defibrillation process. 150 Joules non-escalating, pre-set energy level.
  • Paddles (optional)—Anterior/anterior adult paddles convert to pediatric by removing the outer contacts.
  • Multi-function defibrillator pads—Adult and pediatric pads for defibrillation, ECG monitoring, pacing and synchronized cardioversion.
  • Sterilizable internal paddles—Switch and switchless internal paddles are designed for open-chest defibrillation in the operating room.

 

Lightweight, compact, durable

  • Grab and go—Less than 14 pounds (6.35kg).
  • Compact—Easily fits on a standard hospital stretcher.
  • Rugged—Withstands the rigors of hospital use and patient transport.

 

 

References:

1Page RL, Joglar JA, Kowal RC, et al Use of automated external defibrillators by a U.S. airline. New England Journal of Medicine. 2000;343:1210-1216.
2Capucci A, Aschieri D, Piepoli MF, et al. Tripling survival from sudden cardiac arrest via early defibrillation without traditional education in cardiopulmonary resuscitation. Circulation. 2002;106:1065-1070.
3White RD, Atkinson EJ. Patient outcomes following defibrillation with a low energy biphasic truncated exponential waveform in out-of-hospital cardiac arrest. Resuscitation. 2001;49:9-14.
4Gliner BE, Jorgenson DB, Poole JE, et al. Treatment of out-of-hospital cardiac arrest with a low-energy impedance-compensating biphasic waveform automatic external defibrillation. Biomedical Instrumentation & Technology. 1998;32:631-644. 5White RD, Russell JK. Refibrillation, resuscitation and survival in out-of-hospital sudden cardiac arrest victims treated with biphasic automated external defibrillators. Resuscitation. 2002; 55(1):17-23.
6Gliner BE, White RD. Electrocardiographic evaluation of defibrillation shocks delivered to out-of-hospital sudden cardiac arrest patients. Resuscitation. 1999;41(2):133- 144.
7Poole JE, White RD, Kanz KG, et al. Low-energy impedance-compensating biphasic waveforms terminate ventricular fibrillation at high rates in victims of out-of-hospital cardiac arrest. Journal of Cardiovascular Electrophysiology. 1997;8:1373-1385.
8Caffrey SL, Willoughby PJ, Pepe PF, et al. Public use of automated external defibrillators. New England Journal of Medicine. 2002;347:1242-1247.
9Gurnett CA, Atkins DL. Successful use of a biphasic waveform automated external defibrillator in a high-risk child. American Journal of Cardiology. 2000;86:1051- 1053.
10Martens PR, Russell JK, Wolcke B, et al. Optimal response to cardiac arrest study: defibrillation waveform effects. Resuscitation. 2001;49:233-243.
11White RD, Blackwell TH, Russell JK, Jorgenson DB. Body weight does not affect defibrillation, resuscitation or survival in patients with out-of-hospital biphasic waveform defibrillator. Critical Care Medicine. 2004; 32(9) Supplement: S387-S392.
12White RD, Blackwell TH, Russell JK, Snyder DE, Jorgenson DB. Transthoracic impedance does not affect defibrillation, resuscitation or survival in patients with out-of-hospital cardiac arrest treated with a non-escalating biphasic waveform defibrillator. Resuscitation. 2005 Jan; 64(1):63-69.
13Schneider T, Martens PR, Paschen H, et al. Multicenter, randomized, controlled trial of 150-J biphasic shocks compared with 200- to 360-J monophasic shocks in the resuscitation of out-of-hospital cardiac arrest victims. Circulation. 2000;102:1780-7
14Hess EP, Russell JK, Liu PY, et al. A high peak current 150-J fixed-energy defibrillation protocol treats recurrent ventricular fibrillation (VF) as effectively as initial VF. Resuscitation. 2008 Oct;79(1):28- 33.
15Santomauro M, Borrelli A, Ottaviano L, et al. Transthoracic cardioversion in patients with atrial fibrillation: comparison of three different waveforms. Ital Heart J. Suppl. 2004 Jan; 5(1 Suppl):36-43.
16Page RL, Kerber RE, Russell JK, et al. Biphasic versus monophasic shock waveform for conversion of atrial fibrillation. The results of an international randomized, double-blind multicenter trial. J Am Coll Cardiol. 2002;39:1956-1963.
17Benditt, DG et al. "Biphasic Waveform Cardioversion as an Alternative to Internal Cardioversion for Atrial Fibrillation Refractory to Conventional Monophasic Waveform Transthoracic Shock." Am J Cardiol, December 15, 2001;88(12):1426-1428.

 

 

©2004- Koninklijke Philips Electronics N.V. All rights reserved.